FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213139178> ?p ?o ?g. }

• W4213139178 endingPage "1814" @default.
• W4213139178 startingPage "1805" @default.
• W4213139178 abstract "To analyze disease generalization in patients with ocular myasthenia gravis (OMG) treated with immunosuppression compared with patients without immunosuppression treatment.In this retrospective cohort study, we analyzed data from patients with OMG at seven medical centers in China from January 1, 2015 to May 1, 2019 and compared disease generalization in patients (treated with immunosuppression vs. not treated) within 2 years of disease onset using raw and inverse probability of treatment weighting (IPTW) analyses.In the study population of 813 patients with OMG, 425 (52.3%) with immunosuppression had a mean (SD) onset age of 50.0 (15.1) years, and 188 (44.2%) were women. The remaining 388 (47.7%) patients were not immunosuppressed (mean age, 48.4 [15.0] years; 185 [47.7%] women). Disease generalization developed in 122 (31.4%) and 37 (8.7%) patients in the non-immunosuppression and immunosuppression groups, respectively. Relative to non-immunosuppression, immunosuppression was associated with a lower risk of generalization in a multivariable-adjusted Cox model (hazard ratio [HR] 0.27; 95% confidence interval [CI] 0.18-0.40; p < 0.001) and IPTW-weighted Cox model (HR 0.28; 95% CI 0.19-0.42; p < 0.001). In sensitivity analyses, longer duration of immunosuppression was associated with a lower risk of generalization (HR 0.90 for every 1-month increase; 95% CI 0.87-0.92; p < 0.001; IPTW-adjusted). Combination therapy with steroids and non-steroidal immunosuppressants showed superior efficacy in reducing the risk of generalization (HR 0.14; 95% CI 0.07-0.26; p < 0.001).Immunosuppression significantly reduced the 2-year risk of generalization in patients with OMG." @default.
• W4213139178 created "2022-02-24" @default.
• W4213139178 creator A5000801878 @default.
• W4213139178 creator A5020854396 @default.
• W4213139178 creator A5023013259 @default.
• W4213139178 creator A5035286503 @default.
• W4213139178 creator A5036130651 @default.
• W4213139178 creator A5037954064 @default.
• W4213139178 creator A5042615819 @default.
• W4213139178 creator A5046365551 @default.
• W4213139178 creator A5051284667 @default.
• W4213139178 creator A5053204257 @default.
• W4213139178 creator A5061568176 @default.
• W4213139178 creator A5061779470 @default.
• W4213139178 creator A5062623310 @default.
• W4213139178 creator A5063940082 @default.
• W4213139178 creator A5072364074 @default.
• W4213139178 creator A5073940481 @default.
• W4213139178 date "2022-03-07" @default.
• W4213139178 modified "2023-10-16" @default.
• W4213139178 title "Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis" @default.
• W4213139178 cites W1534349227 @default.
• W4213139178 cites W1974589714 @default.
• W4213139178 cites W1991201329 @default.
• W4213139178 cites W1992225474 @default.
• W4213139178 cites W2008557562 @default.
• W4213139178 cites W2015385567 @default.
• W4213139178 cites W2017405045 @default.
• W4213139178 cites W2028108956 @default.
• W4213139178 cites W2040089716 @default.
• W4213139178 cites W2041684666 @default.
• W4213139178 cites W2047450866 @default.
• W4213139178 cites W2047773382 @default.
• W4213139178 cites W2048517235 @default.
• W4213139178 cites W2053039083 @default.
• W4213139178 cites W2058548181 @default.
• W4213139178 cites W2064349182 @default.
• W4213139178 cites W2078966021 @default.
• W4213139178 cites W2079253050 @default.
• W4213139178 cites W2086132474 @default.
• W4213139178 cites W2089117937 @default.
• W4213139178 cites W2126049444 @default.
• W4213139178 cites W2136714722 @default.
• W4213139178 cites W2140590346 @default.
• W4213139178 cites W2167873595 @default.
• W4213139178 cites W2761621565 @default.
• W4213139178 cites W2806187231 @default.
• W4213139178 cites W2954223196 @default.
• W4213139178 cites W2972592177 @default.
• W4213139178 cites W3094785429 @default.
• W4213139178 cites W3112727477 @default.
• W4213139178 cites W3204700302 @default.
• W4213139178 cites W3208413134 @default.
• W4213139178 cites W4294116629 @default.
• W4213139178 doi "https://doi.org/10.1111/ene.15292" @default.
• W4213139178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35188698" @default.
• W4213139178 hasPublicationYear "2022" @default.
• W4213139178 type Work @default.
• W4213139178 citedByCount "4" @default.
• W4213139178 countsByYear W42131391782022 @default.
• W4213139178 countsByYear W42131391782023 @default.
• W4213139178 crossrefType "journal-article" @default.
• W4213139178 hasAuthorship W4213139178A5000801878 @default.
• W4213139178 hasAuthorship W4213139178A5020854396 @default.
• W4213139178 hasAuthorship W4213139178A5023013259 @default.
• W4213139178 hasAuthorship W4213139178A5035286503 @default.
• W4213139178 hasAuthorship W4213139178A5036130651 @default.
• W4213139178 hasAuthorship W4213139178A5037954064 @default.
• W4213139178 hasAuthorship W4213139178A5042615819 @default.
• W4213139178 hasAuthorship W4213139178A5046365551 @default.
• W4213139178 hasAuthorship W4213139178A5051284667 @default.
• W4213139178 hasAuthorship W4213139178A5053204257 @default.
• W4213139178 hasAuthorship W4213139178A5061568176 @default.
• W4213139178 hasAuthorship W4213139178A5061779470 @default.
• W4213139178 hasAuthorship W4213139178A5062623310 @default.
• W4213139178 hasAuthorship W4213139178A5063940082 @default.
• W4213139178 hasAuthorship W4213139178A5072364074 @default.
• W4213139178 hasAuthorship W4213139178A5073940481 @default.
• W4213139178 hasConcept C126322002 @default.
• W4213139178 hasConcept C167135981 @default.
• W4213139178 hasConcept C17923572 @default.
• W4213139178 hasConcept C207103383 @default.
• W4213139178 hasConcept C2780252810 @default.
• W4213139178 hasConcept C44249647 @default.
• W4213139178 hasConcept C50382708 @default.
• W4213139178 hasConcept C71924100 @default.
• W4213139178 hasConceptScore W4213139178C126322002 @default.
• W4213139178 hasConceptScore W4213139178C167135981 @default.
• W4213139178 hasConceptScore W4213139178C17923572 @default.
• W4213139178 hasConceptScore W4213139178C207103383 @default.
• W4213139178 hasConceptScore W4213139178C2780252810 @default.
• W4213139178 hasConceptScore W4213139178C44249647 @default.
• W4213139178 hasConceptScore W4213139178C50382708 @default.
• W4213139178 hasConceptScore W4213139178C71924100 @default.
• W4213139178 hasFunder F4320321001 @default.
• W4213139178 hasFunder F4320335777 @default.
• W4213139178 hasIssue "6" @default.
• W4213139178 hasLocation W42131391781 @default.

• next